Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Anida Pharma

Anida Pharma?uq=UG6efJS6
2013 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE (Cancelled)
1 INVESTORS
Description

Developer of therapy to treat Parkinson's disease. The company develops new therapies for orphan neurological indications with its current development pipeline focusing on amyotrophic lateral sclerosis.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 155 Brookline Street
  • Suite 005
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Anida Pharma’s full profile, request a free trial.

Anida Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 15-Oct-2015 Cancelled Startup
2. Grant 27-Sep-2013 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Anida Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Michael J. Fox Foundation Limited Partner 000 0000 000000 0

Anida Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Per Gjorstrup MD Founder, President & Chief Executive Officer